Terra Slof Email

Research Technician Molecular Biology . Vico Therapeutics

Current Roles

Employees:
46
Revenue:
$9.2M
About
Bringing knowledge, experience and science together to discover, develop and deliver therapies for CNS disorders. Vico was founded in Q4 2019 by the highly experienced entrepreneurs Luc Dochez and Josh Mandel-Brehm and seasoned scientists Dr. Judith van Deutekom and Dr. Gail Mandel with strong academic reputations and vast industry experience. Together with a team of skilled scientists and drug development professionals, Vico's focus is on development of RNA modulating therapies for rare neurological disorders, with initial focus on SCA – Spinocerebellar ataxia, HD – Huntington's disease and RETT syndrome.
Vico Therapeutics Address
J.H. Oortweg 21
Leiden, null
Vico Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.